---
schema_version: "secwatch.filing_event.v1"
accession: "0001728117-24-000059"
form_type: "8-K"
ticker: "GOSS"
cik: "0001728117"
company_name: "Gossamer Bio, Inc."
filed_at: "2024-05-24T23:59:59+00:00"
generated_at: "2026-06-01T08:46:13.999230+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Gossamer Bio receives Nasdaq minimum bid deficiency; cure period to Nov 18, 2024

## Summary
- Nasdaq notice on May 22, 2024; stock below $1.00 for 30 consecutive business days through May 21.
- Company has 180 calendar days, until November 18, 2024, to regain compliance.
- To cure, closing bid must be at least $1.00 for ten consecutive business days.
- If not cured, may transfer to Nasdaq Capital Market for additional 180 days or face delisting.
- Company may consider a reverse stock split to address the deficiency.

## SEC filing metadata
- accession: 0001728117-24-000059
- form_type: 8-K
- ticker: GOSS
- cik: 0001728117
- company_name: Gossamer Bio, Inc.
- filed_at: 2024-05-24T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1728117/000172811724000059/0001728117-24-000059-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1728117/000172811724000059/goss-20240522.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001728117-24-000059
- JSON: https://secwatch.observer/filing/0001728117-24-000059.json
- Plain text: https://secwatch.observer/filing/0001728117-24-000059.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.